The authors discuss research on skin ulceration risks and oral use of vasodilatory drug nicorandil, conducted by M. T. G. Lee and colleagues, published within the issue. Topics discussed include the adverse effects associated with nicorandil such as nausea and abdominal pain, the investigation into drug safety and exposure outcomes, and the reported clinical dermatology visits of nicorandil users and nonusers.